GRITSTONE ONCOLOGY INC's ticker is GRTS and the CUSIP is 39868T105. A total of 103 filers reported holding GRITSTONE ONCOLOGY INC in Q2 2021. The put-call ratio across all filers is 1.05 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $10 | -16.7% | 6 | 0.0% | 0.00% | – |
| Q2 2023 | $12 | -100.0% | 6 | -100.0% | 0.00% | – |
| Q1 2023 | $49,106 | -38.0% | 17,664 | -23.1% | 0.00% | – |
| Q4 2022 | $79,226 | -84.7% | 22,964 | -88.6% | 0.00% | -100.0% |
| Q3 2022 | $519,000 | -20.4% | 202,037 | -25.0% | 0.00% | -25.0% |
| Q2 2022 | $652,000 | -8.6% | 269,347 | +55.5% | 0.00% | -33.3% |
| Q1 2022 | $713,000 | +29.2% | 173,178 | +303.2% | 0.01% | +20.0% |
| Q4 2021 | $552,000 | -21.5% | 42,956 | -34.0% | 0.01% | -44.4% |
| Q3 2021 | $703,000 | +117.0% | 65,049 | +83.1% | 0.01% | +125.0% |
| Q2 2021 | $324,000 | -1.8% | 35,524 | +1.6% | 0.00% | 0.0% |
| Q1 2021 | $330,000 | +323.1% | 34,952 | +196.7% | 0.00% | +300.0% |
| Q2 2020 | $78,000 | – | 11,780 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Versant Venture Management, LLC | 3,561,150 | $6,125,178 | 3.26% |
| Redmile Group, LLC | 8,509,126 | $14,635,697 | 0.70% |
| Avidity Partners Management LP | 2,733,800 | $4,702,136 | 0.19% |
| Frazier Life Sciences Management, L.P. | 1,430,878 | $2,461,110 | 0.16% |
| Artia Global Partners LP | 95,170 | $163,692 | 0.07% |
| Worth Venture Partners, LLC | 43,772 | $75,288 | 0.04% |
| SkyOak Wealth, LLC | 60,875 | $104,705 | 0.03% |
| Point72 Asset Management, L.P. | 5,924,867 | $10,190,771 | 0.03% |
| CORNERCAP INVESTMENT COUNSEL INC | 76,811 | $132,115 | 0.02% |
| Houlihan Financial Resource Group, Ltd. | 20,000 | $38 | 0.02% |